ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 87 filers reported holding ANTARES PHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $484,000 | -26.1% | 556,754 | +2.8% | 0.00% | 0.0% |
| Q4 2015 | $655,000 | -28.6% | 541,421 | +0.3% | 0.00% | 0.0% |
| Q3 2015 | $917,000 | -19.9% | 539,672 | -1.9% | 0.00% | 0.0% |
| Q2 2015 | $1,145,000 | +23.9% | 550,256 | +61.4% | 0.00% | 0.0% |
| Q1 2015 | $924,000 | +5.8% | 340,842 | +0.4% | 0.00% | 0.0% |
| Q4 2014 | $873,000 | +38.8% | 339,535 | -1.2% | 0.00% | 0.0% |
| Q3 2014 | $629,000 | -30.1% | 343,624 | +2.0% | 0.00% | 0.0% |
| Q2 2014 | $900,000 | -17.7% | 336,901 | +7.9% | 0.00% | -50.0% |
| Q1 2014 | $1,093,000 | -20.9% | 312,236 | +1.0% | 0.00% | 0.0% |
| Q4 2013 | $1,382,000 | +6.6% | 309,207 | -3.2% | 0.00% | 0.0% |
| Q3 2013 | $1,296,000 | +4.2% | 319,332 | +6.8% | 0.00% | 0.0% |
| Q2 2013 | $1,244,000 | – | 299,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |